Extendicare Inc.
EXETFOTCHealthcare● Active
$21.81
+$0.00(+0.00%)
Market Cap$2.1B
P/E Ratio—
52W High$25.95
52W Low$8.62
Extendicare Inc. (EXETF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EXETF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.30
Est. $0.15 · +100.9%
Revenue
$0.33B
Est. $0.31B · +6.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 5-Quarter EPS Beat Streak
EXETF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.28 | — | — | — | $0.41B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $0.15 | $0.30 | +100.9% | $0.33B | $0.31B | +6.4% |
| ▲ Q1 FY2026 | Feb 26, 2026 | $0.19 | $0.21 | +8.0% | $0.34B | $0.35B | -4.8% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $0.13 | $0.27 | +104.8% | $0.28B | $0.42B | -32.2% |
| ▲ Q2 FY2025 | May 6, 2025 | $0.11 | $0.12 | +8.6% | $0.26B | $0.43B | -38.5% |
| ▲ Q1 FY2025 | Feb 27, 2025 | $0.12 | $0.15 | +21.5% | $0.27B | $0.37B | -26.8% |
| — Q4 FY2024 | Nov 12, 2024 | — | $0.14 | — | $0.26B | $0.38B | -30.1% |
| — Q3 FY2024 | Aug 12, 2024 | — | $0.20 | — | $0.25B | $0.25B | +0.6% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.28
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.30
EPS Est.
$0.15
EPS Surpr.
+100.9%
Revenue
$0.33B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$0.21
EPS Est.
$0.19
EPS Surpr.
+8.0%
Revenue
$0.34B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.27
EPS Est.
$0.13
EPS Surpr.
+104.8%
Revenue
$0.28B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$0.12
EPS Est.
$0.11
EPS Surpr.
+8.6%
Revenue
$0.26B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
$0.15
EPS Est.
$0.12
EPS Surpr.
+21.5%
Revenue
$0.27B
Q4 FY2024
Nov 12, 2024
EPS Actual
$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.26B
Q3 FY2024
Aug 12, 2024
EPS Actual
$0.20
EPS Est.
—
EPS Surpr.
—
Revenue
$0.25B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.32 | $0.32 | $0.32 | 1 |
| Q3 FY2028 | $0.30 | $0.30 | $0.30 | 1 |
| Q2 FY2028 | $0.27 | $0.27 | $0.27 | 1 |
| Q1 FY2028 | $0.25 | $0.25 | $0.25 | 1 |
| Q4 FY2027 | $0.31 | $0.31 | $0.31 | 1 |
| Q3 FY2027 | $0.29 | $0.29 | $0.29 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.7B | $0.7B | $0.7B | 1 |
| Q3 FY2028 | $0.6B | $0.6B | $0.6B | 1 |
| Q2 FY2028 | $0.6B | $0.6B | $0.6B | 1 |
| Q1 FY2028 | $0.6B | $0.6B | $0.6B | 1 |
| Q4 FY2027 | $0.6B | $0.6B | $0.6B | 1 |
| Q3 FY2027 | $0.6B | $0.6B | $0.6B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +100.9% | $22.25 | $22.01 | -1.08% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +8.0% | $17.90 | $17.65 | -1.40% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +104.8% | $9.16 | $9.32 | +1.75% |
| ▲ Q2 FY2025 | May 6, 2025 | +8.6% | $10.52 | $10.54 | +0.19% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +21.5% | $8.14 | $8.04 | -1.23% |
| — Q4 FY2024 | Nov 12, 2024 | — | $6.89 | $6.89 | +0.00% |
| — Q3 FY2024 | Aug 12, 2024 | — | $5.46 | $5.46 | +0.00% |
| — Q2 FY2024 | May 15, 2024 | — | $5.61 | $5.72 | +1.96% |
Q2 FY2026-1.08%
Report Date
May 7, 2026
EPS Beat/Miss
+100.9%
Price Before
$22.25
Price After
$22.01
Q1 FY2026-1.40%
Report Date
Feb 26, 2026
EPS Beat/Miss
+8.0%
Price Before
$17.90
Price After
$17.65
Q3 FY2025+1.75%
Report Date
Aug 6, 2025
EPS Beat/Miss
+104.8%
Price Before
$9.16
Price After
$9.32
Q2 FY2025+0.19%
Report Date
May 6, 2025
EPS Beat/Miss
+8.6%
Price Before
$10.52
Price After
$10.54
Q1 FY2025-1.23%
Report Date
Feb 27, 2025
EPS Beat/Miss
+21.5%
Price Before
$8.14
Price After
$8.04
Q4 FY2024+0.00%
Report Date
Nov 12, 2024
EPS Beat/Miss
—
Price Before
$6.89
Price After
$6.89
Q3 FY2024+0.00%
Report Date
Aug 12, 2024
EPS Beat/Miss
—
Price Before
$5.46
Price After
$5.46
Q2 FY2024+1.96%
Report Date
May 15, 2024
EPS Beat/Miss
—
Price Before
$5.61
Price After
$5.72
Avg Beat Reaction-0.35%
Beat Rate5 / 8 quarters
Largest Move+1.96% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EXETF ends December
Extendicare Inc. (EXETF) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.30 — beating the analyst consensus of $0.15 by +100.9%. EXETF has beaten EPS estimates for 5 consecutive quarters. The next EXETF earnings date is expected around September 1, 2026.
Each quarter, investors track EXETF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EXETF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EXETF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EXETF earnings · 5 questionsExtendicare Inc.'s next earnings report is expected around September 1, 2026. EXETF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EXETF historically reports after market close (AMC).
EXETF earnings datewhen is EXETF earningsEXETF next earnings datewhen does EXETF report earningsEXETF earnings calendar
▸ Source: FMP · Extendicare Inc. SEC filings · US GAAP · Extendicare Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026